PMID- 37295831
OWN - NLM
STAT- MEDLINE
DCOM- 20230612
LR  - 20231122
IS  - 2044-6055 (Electronic)
IS  - 2044-6055 (Linking)
VI  - 13
IP  - 6
DP  - 2023 Jun 9
TI  - Timing of adverse events in patients undergoing acute and elective hip 
      arthroplasty surgery: a multicentre cohort study using the Global Trigger Tool.
PG  - e064794
LID - 10.1136/bmjopen-2022-064794 [doi]
LID - e064794
AB  - OBJECTIVE: To explore timing in relation to all types of adverse events (AEs), 
      severity and preventability for patients undergoing acute and elective hip 
      arthroplasty. DESIGN: A multicentre cohort study using retrospective record 
      review with Global Trigger Tool methodology in combination with data from several 
      registers. SETTING: 24 hospitals in 4 major regions of Sweden. PARTICIPANTS: 
      Patients >/=18 years, undergoing acute or elective total or hemiarthroplasty of the 
      hip, were eligible for inclusion. Reviews of weighted samples of 1998 randomly 
      selected patient records were carried out using Global Trigger Tool methodology. 
      The patients were followed for readmissions up to 90 days postoperatively 
      throughout the whole country. RESULTS: The cohort consisted of 667 acute and 1331 
      elective patients. Most AEs occurred perioperatively and postoperatively (n=2093, 
      99.1%) and after discharge (n=1142, 54.1%). The median time from the day of 
      surgery to the occurrence of AE was 8 days. The median days for different AE 
      types ranged from 0 to 24.5 for acute and 0 to 71 for elective patients and 
      peaked during different time periods. 40.2% of the AEs, both major and minor, 
      occurred within postoperative days 0-5 and 86.9% of the AEs occurred within 30 
      days. Most of the AEs were deemed to be of major severity (n=1370, 65.5%) or 
      preventable (n=1591, 76%). CONCLUSIONS: A wide variability was found regarding 
      the timing of different AEs with the majority occurring within 30 days. The 
      timing and preventability varied regarding the severity. Most of the AEs were 
      deemed to be preventable and/or of major severity. To increase patient safety for 
      patients undergoing hip arthroplasty surgery, a better understanding of the 
      multifaceted nature of the timing of AEs in relation to the occurrence of 
      differing AEs is needed.
CI  - (c) Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No 
      commercial re-use. See rights and permissions. Published by BMJ.
FAU - Magneli, Martin
AU  - Magneli M
AUID- ORCID: 0000-0003-0341-0227
AD  - Department of Clinical Sciences at Danderyd Hospital, Karolinska Institute, 
      Stockholm, Sweden martin.magneli@ki.se.
AD  - Department of Orthopaedics, Danderyd University Hospital, Danderyd, Sweden.
FAU - Kelly-Pettersson, Paula
AU  - Kelly-Pettersson P
AUID- ORCID: 0000-0003-3685-2953
AD  - Department of Clinical Sciences at Danderyd Hospital, Karolinska Institute, 
      Stockholm, Sweden.
AD  - Department of Orthopaedics, Danderyd University Hospital, Danderyd, Sweden.
FAU - Rogmark, Cecilia
AU  - Rogmark C
AD  - Department of Clinical Sciences Malmo, Clinical and Molecular Osteoporosis 
      Research Unit, Lund University, Lund, Sweden.
AD  - Department of Orthopaedics, Skane University Hospital Malmo Orthopedics Clinic, 
      Malmo, Sweden.
FAU - Gordon, Max
AU  - Gordon M
AD  - Department of Clinical Sciences at Danderyd Hospital, Karolinska Institute, 
      Stockholm, Sweden.
AD  - Department of Orthopaedics, Danderyd University Hospital, Danderyd, Sweden.
FAU - Skoldenberg, Olof
AU  - Skoldenberg O
AD  - Department of Clinical Sciences at Danderyd Hospital, Karolinska Institute, 
      Stockholm, Sweden.
AD  - Department of Orthopaedics, Danderyd University Hospital, Danderyd, Sweden.
FAU - Unbeck, Maria
AU  - Unbeck M
AD  - Department of Clinical Sciences at Danderyd Hospital, Karolinska Institute, 
      Stockholm, Sweden.
AD  - Hogskolan Dalarna, Falun, Sweden.
LA  - eng
PT  - Journal Article
PT  - Multicenter Study
PT  - Research Support, Non-U.S. Gov't
DEP - 20230609
PL  - England
TA  - BMJ Open
JT  - BMJ open
JID - 101552874
SB  - IM
MH  - Humans
MH  - Retrospective Studies
MH  - Cohort Studies
MH  - *Arthroplasty, Replacement, Hip/adverse effects
MH  - Joints
MH  - Patient Safety
PMC - PMC10277118
OTO - NOTNLM
OT  - Adult orthopaedics
OT  - Hip
OT  - Orthopaedic & trauma surgery
COIS- Competing interests: None declared.
EDAT- 2023/06/10 15:13
MHDA- 2023/06/12 06:42
PMCR- 2023/06/09
CRDT- 2023/06/09 20:53
PHST- 2023/06/12 06:42 [medline]
PHST- 2023/06/10 15:13 [pubmed]
PHST- 2023/06/09 20:53 [entrez]
PHST- 2023/06/09 00:00 [pmc-release]
AID - bmjopen-2022-064794 [pii]
AID - 10.1136/bmjopen-2022-064794 [doi]
PST - epublish
SO  - BMJ Open. 2023 Jun 9;13(6):e064794. doi: 10.1136/bmjopen-2022-064794.